CLARIVEST ASSET MANAGEMENT LLC – Celldex Therapeutics, Inc. Transaction History
CLARIVEST ASSET MANAGEMENT LLC portfolio value:
$2.05M
portfolio value
CLARIVEST ASSET MANAGEMENT LLC quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +344.63% | 56.51K shares | 1.60M | $28.11 | 72.91K |
| Q2 2022 | share | 0.00% | 0 shares | -117K | $26.96 | 16.4K | |
| Q1 2022 | share | Decrease | -12.30% | -2.3K shares | -163K | $34.06 | 16.4K |
| Q4 2021 | share | Decrease | -43.84% | -14.6K shares | -1.07M | $38.9 | 18.7K |
| Q3 2021 | share | Decrease | -0.60% | -200 shares | 678K | $53.99 | 33.3K |
| Q2 2021 | share | Increase | 0.00% | 33.5K shares | 1.12M | $33.44 | 33.5K |